ANXA2 and hereditary clear cell renal cell carcinoma: Previous studies have suggested that ANXA2 is highly upregulated in many malignant tumors, including breast cancer, renal cell carcinoma, colorectal cancer, hepatocellular carcinoma and pancreatic ductal adenocarcinoma [26–30].